Department of Pharmaceutical Technology, Medical University of Gdańsk, Gdańsk, Poland.
Drug Dev Ind Pharm. 2010 Feb;36(2):209-17. doi: 10.3109/03639040903517898.
Coating, as a processing technique, applied to active pharmaceutical ingredient (API) crystals or particles (carriers) with an appropriate polymer allows to obtain a modified-release pharmaceutical dosage form. Such carriers can be the basic ingredient of a multi-unit dosage form. Additionally, coated API crystals (microcapsules) can provide an alternative to spherical granulate (pellets) as the main and most commonly used component of multi-unit dosage forms. Coating individual API crystals is a complicated process because of the crystals having insufficient size (below 100 microm), irregular shape, low mechanical durability and the fact that API crystals dissolve upon contact with the coating mixture, and other factors.
Compaction process was used to eliminate these inconveniences allowing us to obtain tramadol hydrochloride (TH) microcapsule cores in the size range of 212-500 microm. The coating of the cores was successfully conducted using a fluidized-bed coating technique with four different polymers that allowed us to attain slow release of TH. Then, the microcapsules were subjected to a hot tabletting process conducted by applying a low compression force of about 1 kN at 56 degrees C. Semi-liquid granules containing melted PEG 3000 combined with TH microcapsules were compressed. A tablet matrix of good physical parameters was created when its temperature decreased to room temperature. In the proposed hot tabletting method, PEG 3000 included in the granulate provided the tableted microcapsules sufficient protection against rupture.
The compaction process allowed us to eliminate unwanted physical API properties, which could otherwise have an adverse effect on the fluidized-bed coating process. The microcapsule cores after compaction and coating using a fluidized-bed coating technique showed a TH-release profile similar to that of the compressed microcapsules after applying hot tabletting process.
Multi-unit dosage forms can be obtained in a relatively simple way by combining three processes: (i) obtaining TH microcapsule cores by compaction, (ii) coating, and (iii) hot tabletting.
涂层作为一种加工技术,应用于适当的聚合物的活性药物成分 (API) 晶体或颗粒(载体)上,可以获得控释药物剂型。这种载体可以是多单位剂型的基本成分。此外,涂覆的 API 晶体(微胶囊)可以替代球形颗粒(丸剂)作为多单位剂型的主要和最常用的成分。由于晶体的尺寸(小于 100 微米)较小、形状不规则、机械强度低以及 API 晶体在与涂层混合物接触时溶解等原因,对单个 API 晶体进行涂层是一个复杂的过程。
采用压缩工艺消除这些不便,使我们能够获得尺寸范围为 212-500 微米的盐酸曲马多 (TH) 微胶囊核心。使用流化床涂层技术成功地对核心进行了涂层,使用了四种不同的聚合物,使我们能够实现 TH 的缓慢释放。然后,将微胶囊进行热压制表过程,在 56°C 下施加约 1 kN 的低压缩力。含有融化的 PEG 3000 的半液体颗粒与 TH 微胶囊结合后被压缩。当温度降低到室温时,创建了具有良好物理参数的片剂基质。在所提出的热压制表方法中,颗粒中包含的 PEG 3000 为片剂微胶囊提供了足够的保护,防止破裂。
压缩工艺使我们能够消除对流化床涂层过程可能产生不利影响的不必要的物理 API 特性。经过压缩和流化床涂层技术涂覆的微胶囊核心在应用热压制表工艺后显示出与压缩微胶囊相似的 TH 释放曲线。
通过组合三个过程,可以以相对简单的方式获得多单位剂型:(i)通过压缩获得 TH 微胶囊核心,(ii)涂层,和(iii)热压制表。